4.6 Review

mRNP quality control goes regulatory

Journal

TRENDS IN GENETICS
Volume 28, Issue 2, Pages 70-77

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tig.2011.11.001

Keywords

-

Funding

  1. Swiss National Science Foundation [31003A-127614, CRSII3 136222]
  2. European Research Council [StG 207419]
  3. Kanton Bern
  4. Danish National Research foundation
  5. NOVO Nordisk foundation
  6. Lundbeck foundation
  7. Danish Cancer Society
  8. Swiss National Science Foundation (SNF) [CRSII3_136222, 31003A_127614] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

The accuracy of eukaryotic gene expression relies on efficient quality control (QC). Most steps in the gene expression pathway en route from transcription to translation are error-prone and QC systems have evolved to utilise many of these biochemical processes as checkpoints to monitor the production or function of mRNA-protein particles (mRNPs). Mechanistically, such evaluation of mRNP fitness is based on competition between the opposing activities of mRNP biogenesis and/or function and mRNP turnover. In fact, quite subtle alteration of any parameter can tip the balance between mRNP persistence and degradation and, therefore, QC checkpoints also comprise perfect opportunities for controlling cellular levels of individual or even entire families of transcripts. From this perspective, QC and gene regulation represent two outcomes of the same molecular process.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available